Literature DB >> 7955905

Effect of 'autonomic blockade' on cardiac beta-adrenergic chronotropic responsiveness in healthy young, healthy elderly and endurance-trained elderly subjects.

G A Ford1, O F James.   

Abstract

1. Cardiac chronotropic responses to isoprenaline are reduced with ageing in man. It is unclear whether this is due to reduced cardiac beta-adrenergic sensitivity or to age-associated differences in reflex cardiovascular responses to the vasodilatory effects of isoprenaline. Age-associated changes in physical activity are also reported to influence beta-adrenergic sensitivity. 2. The aim of the present study was to determine the contribution of alterations in reflex changes in para-sympathetic and sympathetic influences and physical fitness to the age-associated reduction in cardiac chronotropic responses to beta-adrenergic agonists. 3. The effect of 'autonomic blockade' with atropine (40 micrograms/kg intravenously) and clonidine (4 micrograms/kg intravenously) on blood pressure, heart rate and chronotropic responses to intravenous bolus isoprenaline doses was determined in eight healthy young (mean age 21 years), nine healthy elderly (72 years) and 10 endurance-trained elderly (69 years) subjects. 4. Elderly subjects had a reduced increase in heart rate after atropine (young, 49 +/- 9 beats/min; elderly, 36 +/- 5 beats/min; endurance-trained elderly, 34 +/- 12 beats/min; P < 0.01) and did not demonstrate the transient increase in systolic blood pressure after clonidine observed in young subjects (young, 11 +/- 10 mmHg; elderly, -12 +/- 16 mmHg; endurance-trained elderly, -18 +/- 11 mmHg; P < 0.01). 5. Cardiac chronotropic sensitivity to isoprenaline after 'autonomic blockade' increased in the young but decreased in the elderly subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955905     DOI: 10.1042/cs0870297

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  The cardiovascular system.

Authors:  A Moore; A A Mangoni; D Lyons; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

3.  Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate.

Authors:  Demetra D Christou; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2008-05-15

Review 4.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

5.  Healthy aging does not compromise the augmentation of cardiac function during heat stress.

Authors:  Daniel Gagnon; Steven A Romero; Hai Ngo; Satyam Sarma; William K Cornwell; Paula Y S Poh; Douglas Stoller; Benjamin D Levine; Craig G Crandall
Journal:  J Appl Physiol (1985)       Date:  2016-09-08

6.  In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.

Authors:  Aylin Acun; Trung Dung Nguyen; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2019-05-27       Impact factor: 8.947

7.  Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents.

Authors:  Brad W Wilkins; Christiane Hesse; Hans P Sviggum; Wayne T Nicholson; Thomas P Moyer; Michael J Joyner; John H Eisenach
Journal:  Clin Auton Res       Date:  2006-12-11       Impact factor: 4.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.